TABLE 3.
Percentages of adults and infants immunized using MF59/rgp120 vaccine (Chiron) with detectable V1V2 IgG at peak immunogenicity
V1V2 IgG | Recipients (%) with detectable V1V2 IgG |
P | |
---|---|---|---|
Adults | Infants | ||
gp70 B case A V1V2 | 74 | 96 | 0.005 |
gp70 B case A V1V2 169K | 74 | 93 | 0.018 |
gp70 B case A V1V2 mut 3 | 71 | 89 | 0.056 |
gp70 1086c V1V2 | 67 | 87 | 0.040 |
AE A244 V1V2 tags | 74 | 83 | 0.437 |